Madrigal Pharmaceuticals Presents Phase 3 MAESTRO-NASH Data During the Opening General Session of the EASL Congress™GlobeNewsWire • 06/22/23
Madrigal Pharmaceuticals Announces Participation at Two Upcoming Investor ConferencesGlobeNewsWire • 06/01/23
Madrigal Pharmaceuticals Provides Corporate Updates and Reports First Quarter 2023 Financial ResultsGlobeNewsWire • 05/09/23
Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech NamesBenzinga • 04/20/23
Madrigal (MDGL) Gains on NASH Treatment's Breakthrough Therapy TagZacks Investment Research • 04/19/23
Why Top 1% Biotech Madrigal Pharmaceuticals Just Surged Closer To A BreakoutInvestors Business Daily • 04/18/23
Madrigal Pharmaceuticals Provides Corporate Updates and Reports 2022 Fourth Quarter and Full Year Financial ResultsGlobeNewsWire • 02/23/23